(Q37404476)

20 August 2017

1 reference

title

Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside (English)

1 reference

Neonatal lupus erythematosus

20 August 2017

1 reference

1 reference

Jill P Buyon

1

1 reference

20 August 2017

Robert M Clancy

series ordinal

2

1 reference

20 August 2017

Deborah M Friedman

series ordinal

3

1 reference

20 August 2017

publication date

1 March 2009

1 reference

Nature Clinical Practice Rheumatology

20 August 2017

published in

1 reference

20 August 2017

volume

5

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

139-148

1 reference

Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM1018

Congenital heart block in newborns of mothers with connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM1018

Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM1018

Use of intravenous immunoglobulin G (IVIG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM1018

Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature

21 January 2018

1 reference

12 December 2020

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

1 reference

12 December 2020

Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero

1 reference

12 December 2020

Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al

1 reference

12 December 2020

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission

1 reference

12 December 2020

Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model

1 reference

12 December 2020

Characterization of T-cell population in children with prolonged fetal exposure to dexamethasone for anti-Ro/SS-A antibodies associated congenital heart block.

1 reference

12 December 2020

Autoantibodies against the serotoninergic 5-HT4 receptor and congenital heart block: a reassessment

1 reference

12 December 2020

Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies

1 reference

12 December 2020

Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport.

1 reference

12 December 2020

Cardiac 5-HT(4) serotoninergic receptors, 52kD SSA/Ro and autoimmune-associated congenital heart block.

1 reference

12 December 2020

The effects of pregnancy on autoimmune diseases

1 reference

12 December 2020

Anti-inflammatory actions of intravenous immunoglobulin

1 reference

12 December 2020

Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: implications for progression to scarring in autoimmune-associated congenital heart block.

1 reference

12 December 2020

Reference values for time intervals between atrial and ventricular contractions of the fetal heart measured by two Doppler techniques

1 reference

12 December 2020

Autoantibody-associated congenital heart block: outcome in mothers and children

1 reference

12 December 2020

Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages

1 reference

12 December 2020

Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years

1 reference

12 December 2020

Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus

1 reference

12 December 2020

Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block

1 reference

12 December 2020

Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block

1 reference

12 December 2020

Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women

1 reference

12 December 2020

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

1 reference

12 December 2020

Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling

1 reference

12 December 2020

Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects

1 reference

12 December 2020

Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block.

1 reference

12 December 2020

Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study

1 reference

12 December 2020

Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease

1 reference

12 December 2020

A new therapeutic approach to the fetus with congenital complete heart block: preemptive, targeted therapy with dexamethasone

1 reference

12 December 2020

Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome

1 reference

12 December 2020

Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies

1 reference

12 December 2020

A serologic marker for fetal risk of congenital heart block

1 reference

12 December 2020

Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus

1 reference

12 December 2020

Postnatal progression from second- to third-degree heart block in neonatal lupus syndrome

1 reference

12 December 2020

Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela

1 reference

12 December 2020

Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies

1 reference

12 December 2020

Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts.

1 reference

12 December 2020

Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry

1 reference

12 December 2020

Identifiers

DOI

10.1038/NCPRHEUM1018

1 reference

Dimensions Publication ID

20 August 2017

1002333375

0 references

1 reference